2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol,
Cozaar,
DuP 753,
DuP-753,
DuP753,
Losartan,
Losartan Monopotassium Salt,
Losartan Potassium,
MK 954,
MK-954,
MK954,
Monopotassium Salt, Losartan,
Potassium, Losartan,
Salt, Losartan Monopotassium,
LOSARTAN POTASSIUM,
124750-99-8,
Cozaar,
Lorzaar,
Losaprex,
Hyzaar,
losartanpotassium,
losartan potassium salt,
MK 954,
Lortaan,
Lorzaan,
Losacar,
Losacor,
Tenopres,
Lotim,
Niten,
Ocsaar,
UNII-3ST302B24A,
Losartan Potassium (DuP 753),
Neo Lotan,
MK-0954,
Du Pont 753,
3ST302B24A,
L-158086,
DuP 753,
MK 0954,
Lifezar,
C22H22CIKN6OK,
DuP-753,
ERYTHROPOIETIN,
MK-954,
2-Butyl-4-chloro-1-(2'-(tetrazol-5-yl)biphenyl-4-ylmethyl)-1H-imidazole-5-methanol potassium,
2-Butyl-4-chloro-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)imidazole-5-methanol, monopotassium salt,
2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl]imidazole-5-methanol Potassium Salt,
Covance,
Losartan potassium [USAN:USP],
losartan-potassium,
Nu-Lotan,
potassium 5-(4'-((2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl)methyl)biphenyl-2-yl)tetrazol-1-ide,
potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol,
Cozaar (TN),
MK0954,
DuP-753 potassium,
Losartan potassium,(S),
1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, monopotassium salt,
SCHEMBL42079,
11096-26-7,
MLS001401407,
Ex-89,
DTXSID3044209,
CTK8B3241,
Losartan potassium (JP17/USAN),
HMS2051M12,
HMS2090O22,
HMS2235F20,
HMS3369F08,
HMS3393M12,
ACT02618,
BCP05332,
ANW-42060,
BG0563,
AKOS015955543,
AKOS025310168,
API0003216,
CCG-100869,
Losartan potassium, analytical standard,
NC00119,
RTR-003798,
AN-15300,
CPD000469593,
SAM001246635,
SMR000469593,
AB0072997,
AB2000067,
TR-003798,
L-185,
L0232,
ST24047507,
D00357,
E-3340,
J10063,
AB01275507-01,
750L998,
SR-05000001514,
SR-05000001514-1,
Losartan potassium, European Pharmacopoeia (EP) Reference Standard,
Losartan potassium, United States Pharmacopeia (USP) Reference Standard,
Losartan Potassium, Pharmaceutical Secondary Standard; Certified Reference Material,
1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-((2-(1H-tetrazol-5-yl)(1,1-biphenyl)-4-yl)methyl)-, monopotassium salt,
2-Butyl-4-chloro-1-{[2 inverted exclamation marka-(1H-tetrazol-5-yl)(1,1 inverted exclamation marka-biphenyl)-4-yl]methyl}-1H-imidazole-5-methanol monopotassium salt,
potassium [2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol,
potassium 5-(4'-((2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)tetrazol-1-ide,
potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol.,
Aranesp,
Losata,
Tancin,
Losartan monopotassium salt,
Losartan potassium [USAN],
C22H23ClN6O.K,
HSDB 7043,
C22-H23-Cl-N6-O.K,
CID60771,
MFCD02092704,
ACN-036719,
CS-O-01767,
CID11751549,
A1425,
D004921,
1H-imidazol-5-metanol, 2-butil-4-cloro-1-[[2'-(2H-tetrazol-5-il) [1,1'-bifenilo]] metil]-4-il-, potasio sal (1:1),
1H-Imidazole-5-methanol 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[11'-biphenyl]-4-yl]methyl]-monopotassium salt (9CI),